Evestia Clinical Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 143

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 3

Evestia Clinical General Information

Description

Provider of clinical research services intended for the biotechnology and pharmaceutical sectors. The company offers clinical trial management, regulatory medical writing, clinical monitoring, data management services, biostatistics, medical affairs, quality assurance, pharmacovigilance, and functional service provider solutions, enabling biotech innovators to accelerate the development of complex therapies through specialized clinical research expertise in oncology and rare diseases.

Contact Information

Formerly Known As
EMAS Pharma
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Spirella Building, Bridge Road, Letchworth Garden City
  • Suite 209
  • Hertfordshire SG6 4ET
  • England, United Kingdom
+44 01462
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • Spirella Building, Bridge Road, Letchworth Garden City
  • Suite 209
  • Hertfordshire SG6 4ET
  • England, United Kingdom
+44 01462

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evestia Clinical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evestia Clinical‘s full profile, request access.

Request a free trial

Evestia Clinical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evestia Clinical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Evestia Clinical‘s full profile, request access.

Request a free trial

Evestia Clinical Investments (3)

Evestia Clinical’s most recent deal was a Buyout/LBO with Emtex Life Science. The deal was made on 03-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Emtex Life Science 03-Nov-2026 Buyout/LBO Consulting Services (B2B)
ICRC-Weyer 22-Jan-2026 Buyout/LBO Laboratory Services (Healthcare)
Atlantic Research Group 26-Aug-2025 Buyout/LBO Other Pharmaceuticals and Biotechnology
To view Evestia Clinical’s complete investments history, request access »

Evestia Clinical Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Atlantic Research Group Charlottesville, VA 2004
Emtex Life Science Sint-Gillis-Waas, Belgium 2001
ICRC-Weyer Berlin, Germany 1993

Evestia Clinical FAQs

  • When was Evestia Clinical founded?

    Evestia Clinical was founded in 1996.

  • Where is Evestia Clinical headquartered?

    Evestia Clinical is headquartered in Hertfordshire, United Kingdom.

  • What is the size of Evestia Clinical?

    Evestia Clinical has 143 total employees.

  • What industry is Evestia Clinical in?

    Evestia Clinical’s primary industry is Biotechnology.

  • Is Evestia Clinical a private or public company?

    Evestia Clinical is a Private company.

  • What is Evestia Clinical’s current revenue?

    The current revenue for Evestia Clinical is .

  • Who are Evestia Clinical’s investors?

    Kester Capital has invested in Evestia Clinical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process